HealthBenefits of mRNA cancer vaccines could exceed $75 billion in US alone An analysis of ongoing trials suggests that mRNA cancer vaccines have the potential to deliver health benefits worth $75 billion each year in the US alone News
HealthHow deliberately giving people illnesses is supercharging medicine The covid-19 pandemic opened the door to once-controversial human challenge trials. Now, volunteers are willingly catching norovirus and influenza to reveal how our immune systems really fight back Features